CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02528500
NCT02528500N/ACompleted
CompareCT.gov

Early Feasibility Assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms Involving the Visceral Branch Vessels

W.L.Gore & Associates·interventional·Posted Aug 19, 2015·Updated Jun 28, 2023

In Brief

A clinical study evaluating GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis for Thoracoabdominal Aortic Aneurysm. Completed, enrolled 10 participants across 6 sites.

Detailed Summary

This study will assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in the treatment of Aortic Aneurysms Involving the Visceral Branch Vessels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThoracoabdominal Aortic Aneurysm
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 19, 2015
Enrollment StartNov 1, 2015
Primary CompletionMay 1, 2016
Study CompletionFeb 1, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.9 years ago

Interventions

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesisdevice

Non-randomized, multicenter study designed to assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)